✦ LIBER ✦

Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important?

✍ Scribed by J. DUPONT; C. AGHAJANIAN; G. ANDREA; M. LOVEGREN; S. CHUAI; E. VENKATRAMAN; M. HENSLEY; S. ANDERSON; D. SPRIGGS; P. SABBATINI

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy with pegylated liposomal do

✍ Faruk Tas; Duygu Derin; Nese Guney; Adnan Aydiner; Erkan Topuz 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 229 KB

Recurrent ovarian cancer: Treatment with

✍ Rachel F DEAR; Bo GAO; Paul HARNETT 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Phase II study of the combination of peg

✍ M. VERHAAR-LANGEREIS; A. KARAKUS; M. Van EIJKEREN; E. VOEST; E. WIT 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Cost-minimisation analysis of pegylated

✍ Ojeda, B; de Sande, L M; Casado, A; Merino, P; Casado, M A 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Effectiveness of weekly topotecan in pat

✍ I. VANDENPUT; F. AMANT; P. NEVEN; P. BERTELOOT; K. LEUNEN; I. VERGOTE 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Prospective evaluation of weekly topotec

✍ T. LE; L. HOPKINS; K.A. BAINES; L. RAMBOUT; M. FUNG-KEE-FUNG 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB